MACQUARIE GROUP LTD - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q1 2022$44,000
-29.0%
8,8370.0%0.00%
Q4 2021$62,000
-43.6%
8,837
-19.6%
0.00%
Q3 2021$110,000
+115.7%
10,986
+206.0%
0.00%
Q2 2021$51,000
+168.4%
3,590
+203.2%
0.00%
Q1 2021$19,000
-47.2%
1,184
-32.2%
0.00%
Q4 2020$36,000
+16.1%
1,746
-74.7%
0.00%
Q4 2017$31,0006,9000.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders